ClinicalTrials.gg
CompletedNCT03665012PDCUpdated Sep 10, 2019

The Pediatric Development Clinic Study

An observational study in Pregnancy, Puerperium and Perinatal Conditions, sponsored by Partners in Health. Completed at 1 site in Rwanda. Open to participants aged 1 Week to 5 Years. Per ClinicalTrials.gov, last updated 2019-09-10.

Sponsored by Partners in Health · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
376
Ages
1 Week to 5 Years
Sex
All
01

Study summary

Many preterm, low birth weight and other high-risk infants are surviving the early neonatal period. However, upon discharge from the neonatal units, this at-risk population has little support for their health, nutrition and development in the community. To address this emerging need, Partners In Health in collaboration with the Ministry of Health and UNICEF, has created a pediatric developmental clinic (PDC) to follow the high-risk infants after discharge from hospitals and health centers.

Read the detailed description

Neonatal health and improving neonatal mortality has become one of the top priorities globally. In Rwanda, hospital care has advanced significantly with the development of national neonatal care guidelines and widespread provider training. As advances in technology and resuscitation become more commonly available, many preterm, low birth weight and other high-risk infants are surviving the early neonatal period. However, upon discharge from the neonatal units, this at-risk population has little support for their health, nutrition and development in the community. To address this emerging need, Partners In Health in collaboration with the Ministry of Health and UNICEF, has created a pediatric developmental clinic (PDC) to follow the high-risk infants after discharge from hospitals and health centers. Prior to implementation, a community-based descriptive study assessing the baseline medical, nutritional and developmental needs of low-birth weight and preterm infants who are the target population of the pediatric development clinic was conducted (Baseline Phase One). Subsequently, after 1-2 years of implementation an evaluation of clinical, nutritional and developmental outcomes of children followed in PDC will be conducted in comparison with the baseline study outcomes (Post-PDC Phase Two). Ongoing research on PDC implementation will focus on research on patient and provider experiences, overall clinic processes, cost-effectiveness, expansion of the PDC model, decentralization to health centers, and longer term outcomes of children enrolled in the PDC to further help refine the PDC model (Post-PDC Phase Three)

02

Conditions studied

  • Pregnancy, Puerperium and Perinatal Conditions
03

In context

Lead sponsor

Partners in Health is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Week to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All under-five children in need of formal follow-up with the following medical condition will be enrolled in PDC

  • children born premature
  • children born with an extremely low birth weight (ELBW)/ very low birth weight (VLBW)
  • infants born at term with HIE or Central Nervous System infections (cerebral malaria and meningitis)
  • children with developmental delays,
  • children with trisomy 21, hydrocephalus, cleft lip/palate
  • children less than 12 months of age discharged from the hospital following malnutrition treatment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All under-five children meeting PDC referral criteria as described in the study population description will be enrolled in PDC.

Exclusion criteria

Exclusion Criteria:

  • Patients who do not meet referral criterial for PDC or who are over age 5 years.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
376 participants (actual)
Target follow-up
2 Years
Patient registry
Yes

Interventions

  • OtherPediatric Development Clinic (PDC)

    All children enrolled in PDC will be at screened for any medical condition they may have and be referred for treatment as required. Nutrition and development support are also provided to clinic enrollees, based on clinic protocols which include regular monitoring and intervention.

06

What researchers measure

Primary outcomes

  1. To compare developmental outcomes of children who were enrolled in the PDC to children who did not receive PDC services and to the general population.

    Proportion of children who are on track developmentally measured by the Ages and Stages Questionnaire Version 3 (ASQ-3) and Caregiver Reported Early Childhood Development Index (CREDI).

    Time frame: April 2014 to March 2019

Secondary outcomes

  1. To compare nutritional outcomes of children who were enrolled in the PDC to children who did not receive PDC services and to the general population.

    Proportion of children with normal nutritional status based on anthropometric measures and World Health Organization Growth Standards: weight-for-age (underweight) or weight-for-height (wasting) or length/height-for-age (stunting) z-scores \< -2 (undernutrition) vs healthy (z-score \>-2).

    Time frame: April 2014 to March 2019

07

Study locations

1 site
  • Kirehe District Hospital
    Kirehe, Eastern, Rwanda
08

References and documents

Publications

  • Bayitondere S, Biziyaremye F, Kirk CM, Magge H, Hann K, Wilson K, Mutaganzwa C, Ngabireyimana E, Nkikabahizi F, Shema E, Tugizimana DB, Miller AC. Assessing retention in care after 12 months of the Pediatric Development Clinic implementation in rural Rwanda: a retrospective cohort study. BMC Pediatr. 2018 Feb 16;18(1):65. doi: 10.1186/s12887-018-1007-0. PubMed 29452576 ↗
  • Ngabireyimana E, Mutaganzwa C, Kirk CM, Miller AC, Wilson K, Dushimimana E, Bigirumwami O, Mukakabano ES, Nkikabahizi F, Magge H. A retrospective review of the Pediatric Development Clinic implementation: a model to improve medical, nutritional and developmental outcomes of at-risk under-five children in rural Rwanda. Matern Health Neonatol Perinatol. 2017 Jul 12;3:13. doi: 10.1186/s40748-017-0052-2. eCollection 2017. PubMed 28706729 ↗
  • Nemerimana M, Karambizi AC, Umutoniwase S, Barnhart DA, Beck K, Bihibindi VK, Wilson K, Nshimyiryo A, Bradford J, Havugarurema S, Uwamahoro A, Nsabyamahoro E, Kirk CM. Evaluation of an mHealth tool to improve nutritional assessment among infants under 6 months in paediatric development clinics in rural Rwanda: Quasi-experimental study. Matern Child Nutr. 2021 Oct;17(4):e13201. doi: 10.1111/mcn.13201. Epub 2021 May 7. PubMed 33960693 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual children data can only be shared on request according to the Rwandan policy on data sharing. However, study findings will be shared in different meetings, conferences and journals.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 10, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03665012
Lead sponsor
Partners in Health
Collaborators
Grand Challenges Canada
Responsible party
Catherine Kirk (Director of Maternal and Child Health, Partners in Health) — Principal investigator
First posted
Sep 11, 2018
Start date
Apr 1, 2017
Primary completion
Aug 12, 2019
Completion
Aug 12, 2019
Last update
Sep 10, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion